RxDoctor Payments Data

Debra Placek, MD

Obstetrics & Gynecology · Lincoln, NENPI 1407822174

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.

$2,540in general payments, 2019–2025

Across 125 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$532
  • AbbVie$478
  • Mayne Pharma Commercial LLC$154
  • Bayer$142
  • Organon$120
  • Exeltis, USA Inc.$110
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,540100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,540 in reported general payments places this provider in the 80th percentile of 242 obstetrics & gynecology providers in Nebraska.

See all obstetrics & gynecology providers in Nebraska

Medicare billing

Part B allowed, 2024
$12,689
Medicare patients
162
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol77$2,672
Estradiol (Twice Weekly)Estradiol15$1,017
DottiEstradiol12$752
Sumatriptan Succinate15$152

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →